News & Updates

Cardiovascular drugs do not worsen COVID-19 outcomes

11 Jan 2022 by

Use of cardiovascular medications does not lead to poor COVID-19 clinical outcomes among high-risk patients, such as those with hypertension, according to a study.

Cardiovascular drugs do not worsen COVID-19 outcomes

11 Jan 2022

Newborn screening detects late-onset Pompe disease, allows for early intervention

11 Jan 2022

Newborn screening (NBS) can facilitate the early detection of late-onset Pompe disease, leading to timely intervention, a recent study has found.

Newborn screening detects late-onset Pompe disease, allows for early intervention

11 Jan 2022

PDEV inhibition falls short of improving renal response in patients with preheart failure

11 Jan 2022

The use of a phosphodiesterase type 5 (PDEV) inhibitor in patients with preheart failure (pre-HF) does not appear to produce improvements in glomerular filtration rate and urinary sodium/cGMP excretion as compared with placebo, as shown in a study.

PDEV inhibition falls short of improving renal response in patients with preheart failure

11 Jan 2022

OAC treatment rates in AF patients improve but still far from ideal

10 Jan 2022

The treatment scope of oral anticoagulants (OACs) remains poor despite increasing treatment rates among high-risk atrial fibrillation (AF) patients, which is primarily credited to the expanding direct oral anticoagulant (DOAC) use, reports an Israel study.

OAC treatment rates in AF patients improve but still far from ideal

10 Jan 2022

Transseptal needle approach can recanalize superior vena cava occlusion

09 Jan 2022

A transseptal needle can be used to recanalize the complete long-segment occlusion of the superior vena cava (SVC) without needing to invest further vascular resources, a recent study has found.

Transseptal needle approach can recanalize superior vena cava occlusion

09 Jan 2022

Prior stroke may influence ischaemic stroke risk in cancer patients

07 Jan 2022 by

Prior history of ischaemic stroke appears to affect the risk of ischaemic stroke in patients newly diagnosed with cancer, according to a study from Canada presented at ASH 2021.

Prior stroke may influence ischaemic stroke risk in cancer patients

07 Jan 2022

Anticoagulants achieve favourable outcomes for kids with infection-related CVT

07 Jan 2022

Children with central venous thrombosis (CVT) and associated head or neck infections see good 3-month outcomes after treatment with therapeutic anticoagulants, according to a subgroup analysis of the EINSTEIN-Jr study.

Anticoagulants achieve favourable outcomes for kids with infection-related CVT

07 Jan 2022

Apixaban vs rivaroxaban in AF: Is one better than the other?

06 Jan 2022 by

Rivaroxaban was associated with a greater risk of major ischaemic or haemorrhagic events compared with apixaban in elderly patients with atrial fibrillation (AF) — suggesting that apixaban appears to be preferable over rivaroxaban when considering oral anticoagulant choice in these patients, according to a retrospective cohort study.

Apixaban vs rivaroxaban in AF: Is one better than the other?

06 Jan 2022

Does aspirin increase HF risk?

05 Jan 2022 by

Individuals with risk factors for heart failure (HF) may have an increased risk of developing the condition if they are aspirin users, results of the HOMAGE* study showed.

Does aspirin increase HF risk?

05 Jan 2022

Treatment delay ups coronary artery aneurysm risk in Kawasaki disease patients

05 Jan 2022

In patients with Kawasaki disease, every day that intravenous immunoglobulin (IVIG) treatment is delayed aggravates the risk of developing coronary artery aneurysms (CAA), a recent study has found.

Treatment delay ups coronary artery aneurysm risk in Kawasaki disease patients

05 Jan 2022

News & Updates

Filter by Specialty:

Specialty:

Cardiovascular drugs do not worsen COVID-19 outcomes

Cardiovascular drugs do not worsen COVID-19 outcomes

Newborn screening detects late-onset Pompe disease, allows for early intervention

Newborn screening detects late-onset Pompe disease, allows for early intervention

PDEV inhibition falls short of improving renal response in patients with preheart failure

PDEV inhibition falls short of improving renal response in patients with preheart failure

OAC treatment rates in AF patients improve but still far from ideal

OAC treatment rates in AF patients improve but still far from ideal

Transseptal needle approach can recanalize superior vena cava occlusion

Transseptal needle approach can recanalize superior vena cava occlusion

Prior stroke may influence ischaemic stroke risk in cancer patients

Prior stroke may influence ischaemic stroke risk in cancer patients

Anticoagulants achieve favourable outcomes for kids with infection-related CVT

Anticoagulants achieve favourable outcomes for kids with infection-related CVT

Apixaban vs rivaroxaban in AF: Is one better than the other?

Apixaban vs rivaroxaban in AF: Is one better than the other?

Does aspirin increase HF risk?

Does aspirin increase HF risk?

Treatment delay ups coronary artery aneurysm risk in Kawasaki disease patients

Treatment delay ups coronary artery aneurysm risk in Kawasaki disease patients